Clinical data to cross recognize between Korea and Japan.

Published: 2005-06-24 07:00:00

Updated: 2005-06-24 07:00:00

The pharmaceutical manufacturers associations of Korea and Japan have acknowledged that the mutual recognition of clinical study data would make an important process for commercializing a new drug.

The Korean and Japanese pharmaceutical manufacturers association held a joint seminar in Japan ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK